News Focus
News Focus
Followers 24
Posts 6167
Boards Moderated 0
Alias Born 07/18/2006

Re: BAR123 post# 483782

Tuesday, 02/25/2025 10:34:13 AM

Tuesday, February 25, 2025 10:34:13 AM

Post# of 516615
None of this is new. These topics have been discussed here for years. I don’t think any of these criticisms or suggestions would be new to Missling. Missling does not have any interest in anybody’s advice. He does what he wants and that’s it. He can’t even bother to work with a communications professional to improve his presentation skills. He’s making millions and is unaccountable to his board or to shareholders. He has a job for life. What, then, would be his motivation?

Most of the institutions that hold AVXL are index funds, not actively managed biotech funds. The heavy hitters in biotech are on the sidelines. Whether they don’t believe in the technology or don’t believe in Missling or both is a huge unanswered question. However, Missling has done little to give serious biotech investors comfort.

Nobody should expect Missling to do anything other than what he has been doing all along. After all, it’s worked for him. At this point, Blarcamesine will either be approved or not. That’s it.

If some people are smart enough to make money trading AVXL, good for them.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News